SEI Investments’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
Other funds holding FDMT
SEI Investments's FDMT Position: Q3 2026 in Review
SEI Investments increased its 4D Molecular Therapeutics (FDMT) stake by 200% in Q3 2026, buying an estimated $433K and bringing the position to 49,913 shares worth $714K. The position accounts for ﹤0.01% of the portfolio, ranked #2470.
SEI Investments first reported a position in FDMT in Q1 2024 and has held it in 8 quarters since. 162 funds tracked by Wall St. Rank hold FDMT as of Q3 2026.
- SEI Investments held 49,913 shares of 4D Molecular Therapeutics worth $714K as of Q3 2026.
- SEI Investments bought 33,249 4D Molecular Therapeutics shares in Q3 2026, an estimated $433K.
- 4D Molecular Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2470 holding.
- SEI Investments first reported a position in 4D Molecular Therapeutics in Q1 2024 and has held it in 8 quarters since.
- 162 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.